Venous Thromboembolism Prevention in Nephrotic Syndrome: The Role of Aspirin, Vitamin K Antagonists, and Direct Oral Anticoagulants

By afschroeder • June 10, 2025

Gholizadeh Ghozloujeh Z, Glassock RJ, Al Jurdi A, Jhaveri KD, Heidari-Bateni G, Bajpai D, Lerma E, Wu J, Abdipour A, Norouzi S. Venous Thromboembolism Prevention in Nephrotic Syndrome: The Role of Aspirin, Vitamin K Antagonists, and Direct Oral Anticoagulants. Kidney Int Rep. 2025 Feb 21;10(5):1335-1345. doi: 10.1016/j.ekir.2025.02.010. PMID: 40485694; PMCID: PMC12142514.

Tags: Anticoagulation, Aspirin, Emeritus, Harbor UCLA, hypercoagulability, Nephrology, nephrotic syndrome, Publications, venous thromboembolic events

Dalbavancin for Treatment of Staphylococcus aureus Bacteremia: The DOTS Randomized Clinical Trial

Turner NA, Hamasaki T, Doernberg SB, Lodise TP, King HA, Ghazaryan V, Cosgrove SE, Jenkins TC, Liu C, Sharma S, Zaharoff S, Wahid L, Renard[...]

Evaluating Asparaginase Toxicity in Hispanic Patients With Acute Lymphoblastic Leukemia in a Large Safety-Net Hospital

Zheng D, Dragan M, Jang J, Tomassetti S. Evaluating Asparaginase Toxicity in Hispanic Patients With Acute Lymphoblastic Leukemia in a Large Safety-Net Hospital. World J[...]

Effects of purified eicosapentaenoic acid versus mixed eicosapentaenoic/docosahexaenoic acid pharmacotherapies on coronary plaque volume: network meta-analysis of prospective coronary imaging trials

Sheppard JP, Lakshmanan S, Palatnic L, Dahal S, Roy SK, Bhatt DL, Budoff MJ, Nelson JR. Effects of purified eicosapentaenoic acid versus mixed eicosapentaenoic/docosahexaenoic acid[...]